Pharmadax Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 34.577 million compared to TWD 35.882 million a year ago. Operating loss was TWD 447.186 million compared to TWD 441.853 million a year ago. Net loss was TWD 470.423 million compared to TWD 374.323 million a year ago. Basic loss per share was TWD 8 compared to TWD 6.77 a year ago.